4.6 Article

An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate-to-severe atopic dermatitis

Related references

Note: Only part of the references are listed.
Article Rheumatology

Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database

Peter C. Taylor et al.

Summary: This study reported long-term safety data of baricitinib in patients with active RA, including analysis of various adverse events and assessment of malignancy risk. The conclusions indicated that baricitinib maintained a stable safety profile similar to earlier analyses, with no new safety signals identified.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Dermatology

Risk of herpesvirus, serious and opportunistic infections in atopic dermatitis: a population-based cohort study

J. Wan et al.

Summary: Atopic dermatitis is significantly associated with herpesvirus infections, serious infections, and opportunistic infections, with the risk increasing with the severity of AD.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Dermatology

Association of herpes zoster and chronic inflammatory skin disease in US inpatients

Raj Chovatiya et al.

Summary: Research on patients with chronic inflammatory skin diseases suggests that many CISDs may increase the risk of hospitalization for herpes zoster, indicating the need for further studies and the development of specific vaccination guidelines.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Article Dermatology

Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials

T. Bieber et al.

Summary: This study reports pooled safety data for baricitinib in patients with moderate-to-severe AD, confirming the established safety profile of baricitinib in this population.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Article Dermatology

Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program

Eric L. Simpson et al.

Summary: Abrocitinib has been shown to be an effective treatment for atopic dermatitis with a manageable tolerability and safety profile for long-term use, especially when proper patient and dose selection are utilized. The study results suggest that abrocitinib can be used as a long-term therapy for moderate-to-severe atopic dermatitis.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2021)

Article Allergy

Eczema Herpeticum: Clinical and Pathophysiological Aspects

Alexia Damour et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)

Article Rheumatology

Infections in baricitinib clinical trials for patients with active rheumatoid arthritis

Kevin L. Winthrop et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

Article Dermatology

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

A. Wollenberg et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Article Dermatology

Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis

Lawrence F. Eichenfield et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2019)

Article Dermatology

Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials

Patrick Fleming et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)

Review Dermatology

Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders

Amy Paller et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2018)

Article Rheumatology

Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

Kevin L. Winthrop et al.

ARTHRITIS & RHEUMATOLOGY (2017)

Article Allergy

Asthma as a risk factor for zoster in adults: A population-based case-control study

Hyo Jin Kwon et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Review Allergy

Deciphering the complexities of atopic dermatitis: Shifting paradigms in treatment approaches

Donald Y. M. Leung et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Article Allergy

Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response

Donald Y. M. Leung et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Article Allergy

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum

Lisa A. Beck et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)

Article Dermatology

Predisposing factors and clinical features of eczema herpeticum: A retrospective analysis of 100 cases

A Wollenberg et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)